International Value Investor Takes Strategic Stake in Uscom
Filed with ASX · · 2 pages · English
Earlier from Uscom
- Uscom Receives $492K R&D Cash Refund
- New Hypertension Study Recommends Uscom BP Plus Measures
- Uscom receives GSA listing to sell to US Government
- Uscom BP plus Central Blood Pressure Monitor Released
- BP Plus and Mount Everest Hypertension Study
Later from Uscom
- Share placement
- BP Plus for US eHealth study
- New US IP for Uscom SpiroSonic Devices
- New Uscom Measure of Heart Function
- Uscom releases new hypertension product
Follow Uscom into a list and get an email when it puts out news.
Follow Uscom